DentalMonitoring, a pioneering company in the field of artificial intelligence (AI) for orthodontic treatment monitoring, has achieved a significant milestone by receiving De Novo approval from the U.S. Food and Drug Administration (FDA) for its innovative solution. This groundbreaking approval marks a new era in orthodontics, enabling orthodontists to leverage the power of AI to optimize clinical care and enhance patient experiences.
Empowering Clinicians and Patients With Remote Monitoring
The DentalMonitoring software utilizes advanced image processing algorithms to analyze oral cavity scans captured through the company’s proprietary app and hardware. Philippe Salah, CEO and co-founder of DentalMonitoring, expressed his enthusiasm, stating, “We are proud to be the new standard of care in orthodontics. This is a recognition of our 10 years of research and development in Deep Learning Artificial Intelligence.”
The DentalMonitoring solution is designed to assist healthcare professionals in remotely monitoring dental treatments, orthodontic treatments, oral health, and treatment progress. By providing additional insights compared to traditional follow-ups, the software enhances patient compliance and facilitates effective communication between patients, healthcare providers, and caregivers.
Innovative SmartSTL Feature
Along with the FDA approval, DentalMonitoring will introduce the cutting-edge SmartSTL feature to North American orthodontist customers. This innovative feature allows doctors to request updated STL files through the DentalMonitoring dashboard, eliminating the need for patients to visit the office.
Notably, DentalMonitoring is the first Artificial Intelligence/Machine Learning-enabled Software as a Medical Device in dentistry, establishing a new classification within FDA dental regulation numbers and product codes. With this groundbreaking De Novo approval, DentalMonitoring has paved the way for future innovations in the Software as a Medical Device category for dental care.
As stated by DentalMonitoring, the company’s mission is to “empower orthodontic practitioners with precise, real-time treatment monitoring and decision-making tools.” By enhancing the connection between clinicians and patients, DentalMonitoring aims to optimize treatment outcomes and ensure high-quality, efficient, and personalized orthodontic experiences on a global scale.
The information and viewpoints presented in the above news piece or article do not necessarily reflect the official stance or policy of Dental Resource Asia or the DRA Journal. While we strive to ensure the accuracy of our content, Dental Resource Asia (DRA) or DRA Journal cannot guarantee the constant correctness, comprehensiveness, or timeliness of all the information contained within this website or journal.
Please be aware that all product details, product specifications, and data on this website or journal may be modified without prior notice in order to enhance reliability, functionality, design, or for other reasons.
The content contributed by our bloggers or authors represents their personal opinions and is not intended to defame or discredit any religion, ethnic group, club, organisation, company, individual, or any entity or individual.